| Literature DB >> 35128448 |
Iman Al-Saleh1, Serdar Coskun2, Reem Al-Rouqi1, Tahreer Al-Rajudi1, Chafica Eltabache1, Mai Abduljabbar1, Saad Al-Hassan3.
Abstract
This study examined the status of oxidative stress in 599 couples undertaking in vitro fertilization (IVF) treatment and its association with reproductive hormones, smoking, and outcomes. Oxidative stress biomarkers such as malondialdehyde, 8-hydroxy-2-deoxyguanosine, hydrogen peroxide (H2O2), catalase (CAT), and total antioxidant capacity (TAC) were determined in follicular fluid and seminal plasma. Tail moment (TM) was used to evaluate DNA damage in the sperm and granulosa cells. Reproductive hormones in serum and cotinine (COT) in urine, follicular fluid, and seminal plasma samples were determined. Separate multivariate linear regression was used to assess associations between levels of each oxidative stress biomarker and each hormone and smoking parameter (modeled as natural log-transformed). The findings indicate that some oxidative stress and DNA damage biomarkers played a role in disrupting certain reproductive hormones in women and their male partners either by overproducing reactive oxygen species or reducing antioxidant defense capacity. Although women were nonsmokers, COT levels > 50 and 10 µg/L in urine and follicular were observed in 5.7 and 1.7%, respectively. Levels of follicular fluid COT were positively associated with H2O2 and TM. We used log-binomial multivariate regression to estimate relative risks for the association between oxidative stress/DNA damage and IVF binary outcomes (fertilization rate > 50%, biochemical pregnancy, clinical pregnancy, and live birth). An increase in the CAT levels of follicular fluid was associated with a 48 and 41% decrease in the risk of poor fertilization rate (≤50%) and unsuccessful live birth, respectively. After the models were adjusted for hormonal factors, the associations remained the same, except that the elevated TAC in follicular fluid became significantly associated with a decrease of 42% in the risk of poor fertilization rate (≤50%). The higher antioxidant activity (CAT and TAC) in follicular fluid might positively impact specific IVF outcomes. LAYEntities:
Keywords: DNA damage; IVF; follicular fluid; oxidative stress; reproductive hormones; seminal plasma; smoking
Mesh:
Substances:
Year: 2021 PMID: 35128448 PMCID: PMC8812407 DOI: 10.1530/RAF-20-0062
Source DB: PubMed Journal: Reprod Fertil ISSN: 2633-8386
Figure 1Flow chart of the study population.
Main socio-demographic, lifestyle and health characteristics among 599 IVF couples in Saudi enrolled between 2015 and 2017.
| Variables | Women | Male partners | Couples, | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean± s.d. | Min-max | Reference valuesa | Mean± s.d. | Min-max | Reference valuesa | ||||
| Continuous | |||||||||
| Age (years) | 599 | 32.76 ± 5.02 | 18.7–47.5 | 599 | 37.86 ± 7.39 | 25–72.5 | |||
| BMI (kg/m2) | 599 | 28.56 ± 4.75 | 15.82–42.6 | 597 | 29.79 ± 6.1 | 15.43–50.78 | |||
| Duration trying to conceive (years) | 599 | 6.19 ± 3.69 | 0.5–27 | ||||||
| FSH (IU/L) | 592 | 6.22 ± 3.44 | 0.4–36.6 | 3.5–12.5 | 596 | 5.51 ± 5.87 | 0.1–40.6 | 1.5–12.4 | |
| LH (IU/L) | 589 | 5.57 ± 5.09 | 0.1–62.5 | 2.4–12.6 | 593 | 5.41 ± 3.61 | 0.1–40.8 | 1.7–8.6 | |
| TSH (mU/L) | 598 | 3.49 ± 12.39 | 0.01–243 | 0.27–4.2 | 591 | 2.93 ± 3.52 | 0.01–52.04 | 0.27–4.2 | |
| E2 (pmole/L) | 527 | 151.95 ± 533.11 | 1.29–9849.1 | 46–607 | 454 | 100.52 ± 64.21 | 0.86–782 | 28–156 | |
| Prl (µg/L) | 598 | 14.69 ± 19.32 | 0.14–412 | 4.1–18 | 593 | 45.22 ± 863.29 | 0.5–21032 | 4.1–18 | |
| T (nmol/L) | 562 | 13.73 ± 7 | 0.16–71.61 | ||||||
| Categorical | |||||||||
| Educational levels | |||||||||
| ≤Intermediate | 124 (20.7) | 119 (19.9) | |||||||
| Secondary and diploma | 204 (34.1) | 284 (47.4) | |||||||
| ≥University | 271 (45) | 196 (32.7) | |||||||
| Work status | |||||||||
| Working | 225 (37.6) | 565 (94.3) | |||||||
| Past or never | 374 (62.4) | 34 (5.7) | |||||||
| Smoking cigarettes | |||||||||
| Yes | None | 141 (23.5) | |||||||
| No | None | 458 (76.5) | |||||||
| Smoking water pipes | |||||||||
| Yes | 10 (1.7) | 72 (12) | |||||||
| No | 589 (98.3) | 527 (88) | |||||||
| Living with a male partner and other family members who smoke cigarettes andwater pipes | |||||||||
| Yes | 219 (36.6) | ||||||||
| No | 380 (63.4) | ||||||||
| Regional distribution of residence | |||||||||
| Central | 161 (26.9) | ||||||||
| Eastern | 178 (29.7) | ||||||||
| Western | 77 (12.9) | ||||||||
| Southern | 120 (20.0) | ||||||||
| Northern | 63 (10.5) | ||||||||
| Total monthly family income in Saudi riyals | |||||||||
| <5000 | 66 (11) | ||||||||
| 5001–10,000 | 193 (32.2) | ||||||||
| >10,000 | 168 (28) | ||||||||
| Irregular/unknown/refused | |||||||||
| Causes of infertility | |||||||||
| Female factor | 98 (16.4) | ||||||||
| Male factor | 286 (47.7) | ||||||||
| Combined | 88 (14.7) | ||||||||
| Unexplained factor | 41 (6.8) | ||||||||
| PGD | 86 (14.4) | ||||||||
aReference ranges used at KFSH&RC.
Descriptive statistics of biomarkers in 599 couples.
| Biomarkers | Women | Male partners | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Matrix | Mean | Median | GMa | Max | Matrix | Mean | Median | GMa | Max | |||
| 8-OHdG (µg/L) | FF | 562 | 22.401 | 14.784 | 17.244 | 143.800 | SP | 501 | 175.585 | 138.445 | 142.533c | 960.317 |
| MDA (nmol/mL) | FF | 594 | 0.864 | 0.837 | 0.814b | 5.138 | SP | 580 | 1.021 | 1.010 | 1.091c | 8.011 |
| CAT (U/mL) | FF | 569 | 14.816 | 12.060 | 13.144 | 165.107 | SP | 224 | 11.160 | 9.206 | 10.132 | 56.813 |
| H2O2 (µg/L) | FF | 574 | 6.065 | 5.792 | 5.931 | 18.078 | SP | 232 | 27.532 | 24.618 | 25.161 | 97.726 |
| TAC (µM) | FF | 574 | 728.138 | 741.962 | 676.610 | 1594.687 | SP | 251 | 587.382 | 543.748 | 504.503c | 2061.600 |
| TL | FF | 481 | 73.339 | 70.64 | 70.246 | 148.60 | SP | 278 | 59.217 | 58.5 | 56.596c | 115.04 |
| % DNA tail | GC | 481 | 20.122 | 14.293 | 15.107 | 83.679 | SC | 278 | 16.263 | 15.095 | 14.002c | 46.965 |
| TM | GC | 481 | 8.599 | 4.967 | 5.544 | 57.199 | SC | 278 | 5.248 | 4.483 | 4.193c | 21.766 |
| COT (µg/L) | FF | 574 | 2.442 | 0.000 | 0.278b | 271.298 | SP | 146 | 63.002 | 0.603 | 46.408c | 316.897 |
| COT (µg/L) | Urine | 599 | 46.946 | 3.300 | 3.793b | 8138.636 | Urine | 599 | 2764.453 | 91.948 | 175.097c | 57894.391 |
aGeometric mean calculated after deleting zero values for MDA (n = 19), urinary COT (n = 53), COT (n = 291) in womenb and MDA (n = 70), TL (n = 1), TI (n = 1), TM (n = 1), 8-OHdG (n = 3), TAC (n = 2), urinary COT (n = 23) and COT (n = 69) in male partnersc.
FF, follicular fluid; GC, granulosa cells; GM, geometric mean; SC, sperm cells; SP, seminal plasma.
Inter-correlations among log-transformed oxidative stress biomarkers in women and their male partners (the values in bold denote significant correlations).
| MDA | 8-OHdG | CAT | H2O2 | TAC | TM | |
|---|---|---|---|---|---|---|
| Women | ||||||
| 8-OHdG (µg/L) | ||||||
| | −0.074 | |||||
| | 0.082 | |||||
| | 562 | |||||
| CAT (U/mL) | ||||||
| | −0.018 | |||||
| | 0.671 | |||||
| | 569 | |||||
| H2O2 (µg/L) | ||||||
| | ||||||
| | ||||||
| | ||||||
| TAC (µM) | ||||||
| | -0.043 | 0.041 | ||||
| | 0.312 | 0.332 | ||||
| | 560 | 573 | ||||
| TM | ||||||
| | −0.038 | 0.038 | ||||
| | 0.410 | 0.403 | ||||
| | 476 | 480 | ||||
| Male partners | ||||||
| 8-OHdG (µg/L) | ||||||
| | ||||||
| | ||||||
| | ||||||
| CAT (U/mL) | ||||||
| | 0.127 | |||||
| | 0.058 | |||||
| | 224 | |||||
| H2O2 (µg/L) | ||||||
| | 0.107 | |||||
| | 0.171 | |||||
| | 164 | |||||
| TAC (µM) | ||||||
| | 0.088 | 0.083 | 0.031 | |||
| | 0.167 | 0.192 | 0.718 | |||
| | 249 | 246 | 139 | |||
| TM | ||||||
| | 0.076 | −0.061 | 0.194* | −0.069 | ||
| | 0.209 | 0.504 | 0.022 | 0.407 | ||
| | 276 | 124 | 139 | 148 |
*Correlation is significant at the 0.05 level (two-tailed); **Correlation is significant at the 0.01 level (two-tailed).
Crude and adjusted multiple linear regression modelstesting associations of biomarkers of oxidative stress and DNA damage and reproductive hormones in women and their male partners. Values represent β, regression coefficients, 95% CI, and P, the level of significance. β value corresponds to 1-ln unit change in oxidative stress and DNA damage. The values in bold denote significant associations.
| MDA (nmol/mL) | 8-OHdG (µg/L) | CAT (U/mL) | H2O2 (µg/L) | TAC (µM) | TM | |
|---|---|---|---|---|---|---|
| Women | ||||||
| Reproductive hormones | ||||||
| FSH | −0.007 (−0.093, 0.078), 0.862 | −0.005 (−0.111, 0.098), 0.905 | 0.031 (−0.043, 0.094), 0.464 | −0.014 (−0.037, 0.026), 0.741 | −0.032 (−0.093, 0.041), 0.446 | −0.015 (−0.185, 0.133), 0.748 |
| Adjusteda | −0.021 (-0.111, 0.066), 0.616 | 0.026 (−0.073, 0.138), 0.545 | 0.037 (−0.041, 0.102), 0.407 | −0.016 (−0.039, 0.027), 0.707 | −0.042 (−0.103, 0.035), 0.335 | −0.04 (−0.236, 0.094), 0.397 |
| LH | −0.063 (−0.092, 0.012), 0.127 | 0.044 (−0.009, 0.03), 0.297 | −0.07 (−0.075, 0.006), 0.095 | |||
| Adjusteda | −0.064 (−0.094, 0.012), 0.133 | 0.03 (−0.013, 0.027), 0.407 | −0.063 (−0.073, 0.011), 0.144 | |||
| TSH | 0.032 (−0.035, 0.08), 0.437 | 0.071 (−0.01, 0.129), 0.093 | −0.02 (−0.057, 0.035), 0.641 | 0.002 (−0.043, 0.046), 0.961 | 0.023 (−0.091, 0.154), 0.614 | |
| Adjusteda | 0.03 (−0.037, 0.079), 0.473 | −0.008 (−0.051, 0.042), 0.852 | 0.004 (−0.043, 0.047), 0.924 | 0.021 (−0.11, 0.137), 0.832 | ||
| E2 | 0.001 (−0.043, 0.044), 0.985 | 0.05 (−0.023, 0.084), 0.262 | 0.067 (−0.008, 0.059), 0.133 | 0.013 (−0.014, 0.019), 0.777 | −0.042 (−0.05, 0.017), 0.345 | |
| Adjusteda | 0.005 (−0.042, 0.047), 0.909 | 0.048 (−0.025, 0.083), 0.288 | 0.088 (−0.001, 0.068), 0.058 | 0.003 (−0.016, 0.017), 0.951 | −0.051 (−0.054, 0.015), 0.263 | |
| Prl | −0.044 (−0.089, 0.026), 0.282 | 0.047 (−0.03, 0.109), 0.262 | 0.014 (−0.038, 0.053), 0.734 | −0.01 (−0.024, 0.019), 0.814 | −0. | 0.069 (−0.024, 0.188), 0.131 |
| Adjusteda | −0.039 (−0.086, 0.03), 0.343 | 0.064 (−0.015, 0.121), 0.128 | −0.004 (−0.049, 0.044), 0.925 | −0.015 (−0.025, 0.017), 0.729 | −0.076 (−0.086, 0.004), 0.071 | 0.069 (−0.027, 0.191), 0.138 |
| Smoking parameters | ||||||
| Urinary COT | −0.048 (−0.041, 0.01), 0.241 | 0.053 (−0.011, 0.051), 0.207 | 0.039 (−0.005, 0.014), 0.356 | 0.029 (−0.013, 0.027), 0.489 | 0.019 (−0.037, 0.056), 0.678 | |
| Adjusteda | −0.05 (−0.043, 0.01), 0.237 | 0.051 (−0.013, 0.051), 0.235 | 0.044 (−0.005, 0.015), 0.306 | 0.025 (−0.015, 0.027), 0.57 | 0.007 (−0.044, 0.052), 0.879 | |
| Follicular fluid COT | −0.026 (−0.032, 0.021), 0.669 | −0.044 (−0.075, 0.034), 0.46 | 0.1 (−0.004, 0.053), 0.094 | 0.057 (−0.016, 0.045), 0.338 | ||
| Adjusteda | −0.035 (−0.035, 0.019), 0.574 | −0.021 (−0.063, 0.043), 0.714 | 0.088 (−0.008, 0.051), 0.153 | 0.049 (−0.018, 0.044), 0.412 | ||
| Men | ||||||
| Reproductive hormones | ||||||
| FSH | −0.051 (−0.125, 0.033), 0.254 | −0.006 (−0.078, 0.071), 0.911 | −0.07 (−0.113, 0.034), 0.292 | −0.078 (−0.212, 0.049), 0.219 | −0.094 (−0.235, 0.027), 0.118 | |
| Adjusteda | −0.014 (−0.099, 0.072), 0.764 | −0.008 (−0.088, 0.079), 0.936 | −0.084 (−0.128, −0.033), 0.244 | −0.08 (−0.232, 0.068), 0.267 | −0.075 (−0.221, 0.054), 0.234 | |
| LH | −0.03 (−0.13, 0.065), 0.511 | 0.015 (−0.087, 0.109), 0.825 | −0.028 (−0.107, 0.07), 0.677 | −0.038 (−0.209, 0.112), 0.553 | −0.063 (−0.26, 0.08), 0.299 | |
| Adjusteda | −0.058 (−0.14, 0.024), 0.166 | −0.009 (−0.109, 0.089), 0.845 | 0.02 (−0.087, 0.116), 0.799 | −0.029 (−0.111, 0.071), 0.67 | −0.033 (−0.207, 0.122), 0.61 | −0.026 (−0.213, 0.139), 0.678 |
| Male partners | ||||||
| Reproductive hormones | ||||||
| TSH | 0.068 (−0.013, 0.135), 0.106 | −0.032 (−0.116, 0.054), 0.473 | −0.032 (−0.107, 0.065), 0.633 | −0.011 (−0.082, 0.069), 0.867 | 0.098 (−0.033, 0.279), 0.122 | −0.097 (−0.21, 0.021), 0.107 |
| Adjusteda | 0.047 (−0.031, 0.116), 0.255 | −0.391 (−0.124, 0.05), 0.402 | −0.015 (−0.098, 0.079), 0.832 | −0.052 (−0.109, 0.048), 0.451 | 0.049 (−0.104, 0.225), 0.467 | −0.062 (−0.182, 0.062), 0.331 |
| E2 | −0.083 (−0.179, 0.011), 0.082 | −0.019 (−0.124, 0.085), 0.712 | −0.035 (−0.11, 0.068), 0.64 | −0.093 (−0.224, 0.047), 0.2 | −0.032 (−0.183, 0.112), 0.636 | |
| Adjusteda | −0.09 (−0.19, 0.007), 0.069 | −0.022 (−0.133, 0.087), 0.681 | 0.091 (−0.041, 0.158), 0.248 | −0.033 (−0.115, 0.075), 0.675 | −0.122 (−0.255, 0.023), 0.1 | −0.029 (−0.189, 0.125), 0.69 |
| Prl | −0.023 (−0.124, 0.071), 0.59 | 0.037 (−0.057, 0.14), 0.408 | −0.028 (−0.135, 0.089), 0.684 | 0.028 (−0.091, 0.14), 0.676 | 0.072 (−0.08, 0.292), 0.262 | 0.062 (−0.064, 0.202), 0.308 |
| Adjusteda | −0.029 (−0.132, 0.062), 0.478 | 0.028 (−0.069, 0.132), 0.563 | −0.011 (−0.124, 0.105), 0.871 | −0.003 (−0.123, 0.117), 0.96 | 0.064 (−0.097, 0.287), 0.331 | 0.061 (−0.067, 0.204), 0.322 |
| T | 0.069 (−0.02, 0.203), 0.108 | 0.084 (−0.009, 0.249), 0.069 | 0.093 (−0.038, 0.205), 0.177 | −0.123 (−0.238, 0.011), 0.073 | − | −0.042 (−0.275, 0.134), 0.497 |
| 0.09 (−0.053, 0.216), 0.232 | −0.112 (−0.239, 0.032), 0.133 | −0.111 (−0.39, 0.055), 0.139 | −0.036 (−0.278, 0.159), 0.59 | |||
| Smoking parameters | ||||||
| Urinary COT | −0.065 (−0.03, 0.003), 0.116 | −0.079 (−0.033, 0.002), 0.078 | −0.112 (−0.051, 0.003), 0.078 | 0.036 (−0.018, 0.033), 0.556 | ||
| Adjusteda | −0.075 (−0.033, 0.003), 0.104 | 0.141 (−0.001, 0.036), 0.057 | −0.07 (−0.05, 0.008), 0.15 | 0.046 (−0.016, 0.035), 0.449 | ||
| Seminal plasma COT | 0.105 (−0.025, 0.069), 0.918 | 0.126 (−0.031, 0.107), 0.275 | 0.097 (−0.042, 0.092), 0.458 | 0.187 (−0.018, 0.095), 0.18 | −0.034 (−0.156, 0.121), 0.801 | 0.263 (−0.014, 0.206), 0.085 |
| Adjusteda | 0.147 (−0.027, 0.087), 0.292 | 0.248 (−0.002, 0.153), 0.057 | 0.157 (−0.045, 0.126), 0.348 | −0.082 (−0.225, 0.142), 0.649 | 0.229 (−0.065, 0.233), 0.257 |
aEach model was adjusted for BMI (kg/m2), age (years) educational level (≤intermediate/secondary and diploma/university and above), total monthly family income (<5000/5000–10,000 (reference group)/>10,000/refused or unknown or irregular), regional distribution of residence (central/eastern (reference group)/western/southern/northern], causes of infertility (female factor/male factor (reference group/combined/unexplained factor/PGD), and ln-COT (µg/L).
Adjusted RRs and 95% CIs for %fertilization rate, biochemical pregnancy, clinical pregnancy, and live birth in association with biomarkers using binomial regression estimates (each modeled separately). The values in bold denote significant associations.
| Biomarkers | %Fertilization rate | Biochemical pregnancy | Clinical pregnancy | Live birth |
|---|---|---|---|---|
| MDA-women | ||||
| Adjusted for factorsa + ln-COT* | 0.885 (0.645, 1.22), 0.45 | 1.161 (0.843, 1.60), 0.36 | 1.139 (0.813, 1.60), 0.45 | 1.139 (0.797, 1.63), 0.47 |
| Adjusted for factorsa + ln-COT* and PC1b | 0.914 (0.647, 1.291), 0.611 | 1.167 (0.825, 1.652), 0.383 | 1.198 (0.832, 1.727), 0.331 | 1.171 (0.791, 1.735), 0.43 |
| MDA-male partners | ||||
| Adjusted for factorsa + ln-COT* | 0.866 (0.665, 1.129), 0.288 | 0.974 (0.739, 1.283), 0.851 | 1.091 (0.818, 1.457), 0.552 | 1.145 (0.847, 1.548), 0.38 |
| Adjusted for factorsa + ln-COT* and PC1c | 0.968 (0.693, 1.354), 0.851 | 0.95 (0.677, 1.334), 0.767 | 1.063 (0.741, 1.525), 0.74 | 1.052 (0.721, 1.535), 0.792 |
| 8-OHdG-women | ||||
| Adjusted for factorsa + ln-COT* | 0.822 (0.613, 1.10), 0.189 | 0.805 (0.603, 1.08), 0.142 | 0.784 (0.577, 1.07), 0.12 | 0.778 (0.563, 1.08), 0.128 |
| Adjusted for factorsa + ln-COT* and PC1b | 0.773 (0.559, 1.07), 0.121 | 0.855 (0.625, 1.171), 0.33 | 0.825 (0.591, 1.151), 0.258 | 0.803 (0.564, 1.145), 0.226 |
| 8-OHdG-male partners | ||||
| Adjusted for factorsa + ln-COT* | 0.927 (0.683, 1.257), 0.625 | 0.734 (0.536, 1.005), 0.054 | 0.721 (0.516, 1.007), 0.055 | 0.746 (0.523, 1.064), 0.105 |
| Adjusted for factorsa + ln-COT* and PC1c | 0.929 (0.647, 1.334), 0.691 | 0.706 (0.488, 1.021), 0.064 | 0.721 (0.487, 1.066), 0.101 | 0.756 (0.5, 1.145), 0.186 |
| CAT-women | ||||
| Adjusted for factorsa + ln-COT* | 0.853 (0.563, 1.29), 0.454 | 0.72 (0.466, 1.11), 0.137 | ||
| Adjusted for factorsa + ln-COT* and PC1b | 0.857 (0.533, 1.377), 0.524 | 0.755 (0.459, 1.243), 0.269 | ||
| CAT-male partners | ||||
| Adjusted for factorsa + ln-COT* | 0.784 (0.362, 1.695), 0.536 | 0.589 (0.254, 1.368), 0.218 | 0.588 (0.252, 1.369), 0.218 | 0.753 (0.308, 1.841), 0.534 |
| Adjusted for factorsa + ln-COT* and PC1c | 0.661 (0.236, 1.849), 0.43 | 0.772 (0.26, 2.294), 0.641 | 0.765 (0.248, 2.353), 0.64 | 0.828 (0.273, 2.513), 0.739 |
| H2O2-women | ||||
| Adjusted for factorsa + ln-COT* | 0.917 (0.369, 2.28), 0.852 | 0.674 (0.274, 1.66), 0.39 | 0.594 (0.231, 1.53), 0.522 | 0.487 (0.18, 1.32), 0.156 |
| Adjusted for factorsa + ln-COT* and PC1b | 0.806 (0.302, 2.152), 0.666 | 0.913 (0.348, 2.399), 0.854 | 0.714 (0.258, 1.974), 0.516 | 0.582 (0.198, 1.716), 0.327 |
| H2O2-male partners | ||||
| Adjusted for factorsa + ln-COT* | 1.096 (0.534, 2.249), 0.802 | 0.888 (0.417, 1.891), 0.757 | 0.786 (0.36, 1.716), 0.545 | 0.744 (0.319, 1.735), 0.494 |
| Adjusted for factorsa + ln-COT* and PC1c | 1.651 (0.707, 3.854), 0.246 | 1.088 (0.469, 2.526), 0.844 | 0.914 (0.383, 2.178), 0.838 | 0.936 (0.372, 2.353), 0.888 |
| TAC-women | ||||
| Adjusted for factorsa + ln-COT* | 0.748 (0.493, 1.13), 0.171 | 0.853 (0.55, 1.32), 0.478 | 0.938 (0.594, 1.48), 0.784 | 1.049 (0.653, 1.68), 0.844 |
| Adjusted for factorsa + ln-COT* and PC1b | 0.745 (0.451, 1.23), 0.25 | 0.731 (0.428, 1.248), 0.251 | 0.829 (0.477, 1.441), 0.507 | |
| TAC-male-partners | ||||
| Adjusted for factorsa + ln-COT* | 1.054 (0.664, 1.673), 0.823 | 1.052 (0.688, 1.608), 0.815 | 1.047 (0.684, 1.602), 0.834 | 0.917 (0.548, 1.537), 0.743 |
| Adjusted for factorsa + ln-COT* and PC1c | 1.872 (0.854, 4.102), 0.117 | 1.413 (0.679, 2.94), 0.356 | 1.125 (0.542, 2.332), 0.753 | 0.938 (0.431, 2.039), 0.871 |
| TM-women | ||||
| Adjusted for factorsa + ln-COT* | 1.087 (0.875, 1.35), 0.452 | 0.958 (0.77, 1.19), 0.698 | 0.924 (0.734, 1.16), 0.5 | 1.062 (0.829, 1.36), 0.635 |
| Adjusted for factorsa + ln-COT* and PC1b | 1.017 (0.8, 1.293), 0.889 | 0.951 (0.75, 1.206), 0.68 | 0.92 (0.717, 1.181), 0.514 | 1.03 (0.785, 1.351), 0.83 |
| TM-male partners | ||||
| Adjusted for factorsa + ln-COT* | 1.073 (0.722, 1.595), 0.727 | 0.775 (0.509, 1.18), 0.235 | 0.678 (0.406, 1.132), 0.137 | |
| Adjusted for factorsa + ln-COT* and PC1c | 1.065 (0.641, 1.771), 0.805 | 0.767 (0.459, 1.281), 0.31 | 0.584 (0327, 1.042), 0.069 | 0.708 (0.387, 1.293), 0.261 |
aAge (years), BMI (kg/m2), causes of infertility (Female factor/male factor (reference group)/combined/unexplained factor/PGD), regional distribution of residence (central/eastern (reference group)/western/southern/northern), educational level (≤intermediate/secondary and diploma/university and above (reference group)), total monthly family income (<5000/5000–10,000 (reference group)/>10,000/refused or unknown or irregular); bPC1 (FSH, LH and E2); cPC1 (FSH and LH). *ln-COT (µg/L).